Final Pr. ID: Poster #: CR-030
PET/CT plays an important role in assessing response to therapy in patients undergoing treatment for Hodgkin’s lymphoma (HL). A negative PET/CT following completion of chemotherapy has a high negative predictive value (>95%) for disease progression, relapse, or recurrence. Thus treatment decisions, including the decision to pursue radiation therapy or to alter chemotherapy regimens, are often made based on PET/CT results. Given the treatment implications, obtaining accurate PET/CT results is of the utmost importance. Read More
Authors: Foust Alexandra , Voss Stephan
Keywords: Abnormal FDG uptake in white fat, gluconeogenesis, Hodgkin lymphoma therapy implications